Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR: ESBL-E Eradication in High-Risk Patients
NCT01931592Phase 3Terminated
- Start
- Jan 2014
- Primary completion
- Oct 2016
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of fosfomycin, colistin, gentamicin in Enterobacteriaceae colonization. Started Jan 2014; status: terminated.
02
Drugs
fosfomycincolistingentamicin
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT01931592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931592.